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We read with great interest the recent review article by Vee-
nith et al. published in the World Journal of Emergency Sur-
gery [1]. In this paper, the authors provide an overview on
the epidemiology and pathophysiology of traumatic brain
injury (TBI), and present an update on TBI-induced apop-
tosis, intracranial gene regulation and pharmacological
approaches to ameliorate secondary brain injury. The
authors are to be congratulated for outlining this impor-
tant and constantly evolving topic of global importance.
Unfortunately, our initial excitement about this paper,
which promised to disclose the "missing link" between
molecular pathology and new treatment concepts for TBI
[1], was not justified. We believe that important pathways
in the pathophysiology of TBI and resulting therapeutic
concepts were not addressed in the review article. We
would therefore like to comment on the missing aspects
in the article by Veenith and colleagues [1], in order to
provide a more balanced and comprehensive perspective
on the topic.
Beyond a doubt, a detailed description of the molecular
neuropathology of TBI represents a challenging task,
which is difficult to describe in just a few paragraphs.
However, the authors could have expanded their article to
include some of what we consider "key" pathways in the
cellular and molecular pathophysiology of TBI (Figure 1).
For example, the role of neurotoxic proteases, nitric oxide
and phospholipases released by damaged tissue, the
impact on blood-brain-barrier breakdown by recruited
and local inflammatory cells, and the activation of the
innate immune system, e.g. the complement system, as a
crucial mediator of posttraumatic neuroinflammation,
are not mentioned or discussed in the paper. The section
devoted to apoptosis provides the reader with some basic
textbook information and definitions, but may have ben-
efited from an additional update on the current literature
in the field of neuronal apoptosis in TBI. Similarly, the
paragraph on gene regulation appears to represent a ran-
dom selection of candidate genes without a rationale
being provided on how alterations in gene regulation may
relate to the pathophysiology of TBI. Several references
cited refer to studies related to cardiovascular disease,
rather than head injury. Most importantly, this section of
the manuscript fails to stress the clinical relevance of path-
ological alterations in gene expression.
Finally, as a minor comment, the authors should pay
more attention to accuracy in the citation of the pertinent
literature. For example, reference #10 is claimed to sup-
port a statement on interleukins and cerebral edema,
when in fact the citation refers to a publication on pro-
grammed cell death in nematodes. Several other examples
of inadequate reference to the literature could be men-
tioned. Finally, the title chosen by the authors appears
problematic. The authors claim to provide the "missing
link"  between molecular mechanisms and therapeutic
concepts in TBI. Unfortunately, the review article fails to
provide a bridge between the two entities. In addition,
many of the current therapeutic approaches and promis-
ing new strategies in search of the pharmacological
"golden bullet" are missing [2]. While alterations in gene
expression may be an interesting finding and promising
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target for future scientific approaches, we are still far from
bringing the gene therapy concept from "bench to bed-
side" for an acute traumatic disorder such as TBI.
In summary, we realize that providing an encompassing
and scientifically accurate review on the topic represents a
virtually impossible task. We are therefore grateful for the
review by Veenith et al. [1] and we hope to contribute to
the authors' search of the "missing link" between molecu-
lar pathophysiology and new therapeutic concepts in TBI
by the identification of additional pathways of interest
(Fig. 1).
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Simplified schematic of the complex neuroinflammatory response following traumatic brain injury Figure 1
Simplified schematic of the complex neuroinflammatory response following traumatic brain injury. Check-
marks indicate the areas discussed in the review article by Veenith and colleagues [1], while the red boxes designate patho-
physiological pathways of additional interest.